Keywords
Diabetes mellitus
Global longitudinal strain
Silent myocardial ischaemia
Speckle tracking echocardiography
How to Cite
Abstract
Background: Diabetes mellitus is a major risk factor for cardiovascular events. A significant proportion of diabetics are asymptomatic for ischaemic heart disease either because of the early stage of ischaemia or silent myocardial ischaemia. Global longitudinal strain (GLS) of the left ventricle measured by speckle tracking echocardiography (STE) is a novel method of detecting left ventricular dysfunction due to myocardial ischaemia.
Objectives: This study aimed to compare the GLS of type-2 diabetes mellitus (T2DM) and non-diabetic patients who were asymptomatic for coronary artery disease (CAD).
Methods: An analytical cross-sectional study was conducted among 52 diabetic and 49 non-diabetic individuals asymptomatic for CAD presenting to a tertiary hospital, between 2022 September to 2022 October. The STE was performed to measure left ventricular GLS of the participants. Their blood and urine samples were sent for measuring glycosylated haemoglobin (HbA1c), total cholesterol, and microalbuminuria. Data were entered and analysed using SPSS v23.
Results: Twenty-five (48.1%) diabetics had left ventricular dysfunction (GLS ?18) compared to two (4.1%) non-diabetics. GLS was significantly lower among the diabetic patients, and exhibited significant inverse correlation with the duration of diabetes, age, HbA1c, and microalbuminuria (p <0.001). In multiple linear regression model for GLS, only the duration of diabetes (B = -0.27, p <0.001) and the age of patients (B = -0.057, p = 0.004) retained statistical significance, after adjusting for other covariates.
Conclusion: Left ventricular GLS has a significant negative correlation with the duration of diabetes and age of the patients.
References
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019 Nov;157:107843. [PubMed | Full Text | DOI]
Shrestha N, Karki K, Poudyal A, Aryal KK, Mahato NK, Gautam N, et al. Prevalence of diabetes mellitus and associated risk factors in Nepal: Findings from a nationwide population-based survey. BMJ Open. 2022;12(2):e060750. [PubMed | Full Text | DOI]
Global burden of disease collaborative network. Global burden of disease study 2019 results [Internet]. Washington: Global Burden of Disease Collaborative Network, Institute for Health Metrics and Evaluation (IHME). 2020 [cited 2022 Sep 10]. Available from: https://vizhub.healthdata.org/gbdresults/ [Full Text]
Sara JD, Taher R, Kolluri N, Vella A, Lerman LO, Lerman A. Coronary microvascular dysfunction is associated with poor glycaemic control amongst female diabetics with chest pain and nonobstructive coronary artery disease. Cardiovasc Diabetol 2019;18(1):22. [PubMed | Full Text | DOI]
Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Endocr Rev. 2004;25(4):543-67. [PubMed | Full Text | DOI]
Hernández C, Candell-Riera J, Ciudin A, Francisco G, Aguadé-Bruix S, Simó R. Prevalence and risk factors accounting for true silent myocardial ischaemia: A pilot case-control study comparing type 2 diabetic with non-diabetic control subjects. Cardiovasc Diabetol. 2011 Jan 21;10:9. [PubMed | Full Text | DOI]
Wackers FJ, Young LH, Inzucchi SE, Chyun DA, Davey JA, Barrett EJ, et al. Detection of silent myocardial ischaemia in asymptomatic diabetic subjects: The diad study. Diabetes Care. 2004 Aug;27(8):1954-61. [PubMed | Full Text | DOI]
Cosson E, Attali JR, Valensi P. Markers for silent myocardial ischaemia in diabetes: Are they helpful? Diabetes Metab. 2005;31(2):205-13. [PubMed | Full Text | DOI]
Conte L, Fabiani I, Barletta V, Bianchi C, Maria CA, Cucco C, et al. Early detection of left ventricular dysfunction in diabetes mellitus patients with normal ejection fraction, stratified by BMI: A preliminary speckle tracking echocardiography study. J Cardiovasc Echogr. 2013 Jul-Sep;23(3):73-80. [PubMed | Full Text | DOI]
Kaushik A, Kapoor A, Dabadghao P, Khanna R, Kumar S, Garg N, et al. Use of strain, strain rate, tissue velocity imaging, and endothelial function for early detection of cardiovascular involvement in young diabetics. Ann Pediatr Cardiol. 2021 JanMar;14(1):1-9. [PubMed | Full Text | DOI]
Valensi P, Lorgis L, Cottin Y. Prevalence, incidence, predictive factors and prognosis of silent myocardial infarction: A review of the literature. Arch Cardiovasc Dis. 2011 Mar;104(3):178-88. [PubMed | Full Text | DOI]
Yang H, Wright L, Negishi T, Negishi K, Liu J, Marwick TH. Research to practice: Assessment of left ventricular global longitudinal strain for surveillance of cancer chemotherapeutic-related cardiac dysfunction. JACC Cardiovasc Imaging. 2018 Aug;11(8):1196-201. [PubMed | Full Text | DOI]
Bajracharya P, Acharya KP, Banerjee SK, Ahmed CM, Alam MM, Arzu J, et al. Correlation between myocardial Strain by 2-D speckle-tracking echocardiography and angiographic findings by coronary angiogram in stable angina. Maedica (Bucur). 2020 Sep;15(3):365-72. [PubMed | Full Text]
Grubi? Rotkvi? P, Planini? Z, Liberati Pršo AM, Šiki? J, Gali? E, Rotkvi? L. The mystery of diabetic cardiomyopathy: from early concepts and underlying mechanisms to novel therapeutic possibilities. Int J Mol Sci. 2021;22(11):5973. [PubMed | Full Text | DOI]
Medvedofsky D, Kebed K, Laffin L, Stone J, Addetia K, Lang RM, et al. Reproducibility and experience dependence of echocardiographic indices of left ventricular function: Side-by-side comparison of global longitudinal strain and ejection fraction. Echocardiography. 2017 Mar;34(3):365-70. [PubMed | Full Text | DOI]
Cimino S, Canali E, Petronilli V, Cicogna F, De Luca L, Francone M, et al. Global and regional longitudinal strain assessed by two-dimensional speckle tracking echocardiography identifies early myocardial dysfunction and transmural extent of myocardial scar in patients with acute ST elevation myocardial infarction and relatively preserved LV function. Eur Heart J Cardiovasc Imaging. 2013 Aug;14(8):805-11. [PubMed | Full Text | DOI]
Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol. 2001 Feb 1;87(3):320-3. [PubMed | Full Text | DOI]
Liao L, Shi B, Ding Z, Chen L, Dong F, Li J, et al. Echocardiographic study of myocardial work in patients with type 2 diabetes mellitus. BMC Cardiovasc Disord. 2022 Feb 17;22(1):59. [PubMed | Full Text | DOI]
Johnston MC, Crilly M, Black C, Prescott GJ, Mercer SW. Defining and measuring multimorbidity: A systematic review of systematic reviews. Eur J Public Health. 2019 Feb 1;29(1):182-9. [PubMed | Full Text | DOI]
Khadka T, Giri GK, Mandal D, Shrestha A, Dhungel A, Vaidya A. Multimorbidity in diabetic patients admitted to a tertiary care centre: A descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2023 Jan 1;61(257):50-3. [Full Text | DOI]